Literature DB >> 15492590

Poor coronary collateral circulation is associated with higher concentrations of soluble adhesion molecules in patients with single-vessel disease.

Umit Guray1, Ali Riza Erbay, Yesim Guray, Mehmet Birhan Yilmaz, Asiye Ayca Boyaci, Hatice Sasmaz, Sule Korkmaz, Emine Kutuk.   

Abstract

OBJECTIVE: As the endothelium and inflammatory cells play a crucial role in the development of collaterals after a sudden or slowly progressing stenosis of coronary arteries, the levels of soluble endothelial adhesion molecules (CAMs) including vascular cell adhesion molecule (VCAM-1) intercellular adhesion molecule-1 (ICAM-1) and E-selectin were compared between patients with poor coronary collaterals and patients with well-developed collaterals.
METHODS: In the study, 97 non-diabetic subjects with single-vessel disease were included. Collateral supply to the stenotic coronary artery was determined by angiographic grading system of 0-3 (Rentrop et al. J Am Coll Cardiol 1985; 5:587-592). Serum levels of adhesion molecules were measured by enzyme-linked immunosorbent assay.
RESULTS: Patients were divided into two groups according to the collateral degree (group A: 50 patients with grade 0 and 1; group B: 47 patients with grade 2 and 3 collaterals). The groups were well matched with respect to baseline clinical and angiographic characteristics. Levels of soluble VCAM-1 (mean+/-SEM; 875+/-26.6 versus 742.7+/-35.1 ng/ml; P=0.004), ICAM-1 (322.4+/-12.4 versus 269.4+/-13.3 ng/ml; P=0.005), and E-selectin (43.6+/-2.6 versus 33+/-2.4 ng/ml; P=0.004) were found to be significantly higher in group A in comparison with group B. In addition, when patients were divided into four groups according to the collateral degree, patients with grade 0 collaterals had the highest values and those with grade 3 collaterals had the lowest values for all these molecules.
CONCLUSIONS: We concluded that poor collateral circulation is associated with increased levels of soluble CAMs in patients with obstructive coronary artery disease. However, further studies are needed to elucidate the exact role of these inflammatory markers in the setting of poor collateral circulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15492590     DOI: 10.1097/00019501-200411000-00008

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  4 in total

1.  Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion.

Authors:  Samim Emet; Ali Elitok; Imran Onur; Mehmet Kocaaga; Ahmet Kaya Bilge; Huseyin Oflaz; Berrin Umman; Aytac Oncul; Zehra Bugra; Kamil Adalet; Fehmi Mercanoglu
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

2.  Clinical and angiographic features associated with coronary collateralization in stable angina patients with chronic total occlusion.

Authors:  Zhen Sun; Ying Shen; Lin Lu; Rui-yan Zhang; Li-jin Pu; Qi Zhang; Zheng-kun Yang; Jian Hu; Qiu-jing Chen; Wei-feng Shen
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

3.  Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion.

Authors:  Ying Shen; Feng Hua Ding; Rui Yan Zhang; Qi Zhang; Lin Lu; Wei Feng Shen
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

4.  Predictors of poor coronary collateral development in patients with stable coronary artery disease: neutrophil-to-lymphocyte ratio and platelets.

Authors:  Fatih Akın; Burak Ayça; Ömer Çelik; Cem Şahin
Journal:  Anatol J Cardiol       Date:  2014-04-08       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.